Graphene Investments Sas Jazz Pharmaceuticals PLC Transaction History
Graphene Investments Sas
- $137 Billion
- Q1 2025
A detailed history of Graphene Investments Sas transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Graphene Investments Sas holds 20,600 shares of JAZZ stock, worth $2.28 Million. This represents 1.87% of its overall portfolio holdings.
Number of Shares
20,600
Previous 24,200
14.88%
Holding current value
$2.28 Million
Previous $2.98 Billion
14.18%
% of portfolio
1.87%
Previous 2.06%
Shares
6 transactions
Others Institutions Holding JAZZ
# of Institutions
554Shares Held
59.8MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$681 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$669 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$280 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$245 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$225 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.95B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...